Transcode Therapeutics, Inc. · NASDAQ:RNAZ

Goldman Sachs Group Inc's stake in Transcode Therapeutics, Inc. fell below 5% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 10, 2025

Goldman Sachs Group Inc's stake in Transcode Therapeutics, Inc. fell below 5%, 82 shares, as a passive investor on Sep 30, 2025. Filed Nov 10, 2025 (Schedule 13G/A).

Stake
0%
Shares
82
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.0%82
GOLDMAN SACHS & CO. LLC0%82

Source

View original at SEC

Related